Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

Emphasizing the One Health Approach and Urgent Need for Antimicrobial Stewardship Programmes: Insights from EuroAsia 2024

NextEdge Admin

25 Jun 2024

3 min 14 sec

During EuroAsia 2024, critical care specialists highlighted antimicrobial resistance (AMR) as a pressing global issue affecting health across humans, animals, and the environment, ranking among humanity's top challenges. Experts such as Dr. Bharat Jagiasi, Dr. Pradip Bhattacharya, Dr. Srinivas Samavedam, Dr. Pradeep Rangappa, Dr. Rajesh Pande, and others stressed the urgency of combating AMR through a comprehensive 'One Health' approach.

Dr. Bharat Jagiasi, General Secretary of ISCCM, underscored the need for aggressive action against AMR, advocating for enhanced antimicrobial stewardship and public education. He emphasized that AMR prolongs hospital stays, increases treatment duration, and raises mortality rates, necessitating strengthened hygiene measures and infection prevention strategies.

Prof. Dr. Pradip Bhattacharya, President of ISCCM, highlighted India's significant AMR burden, citing data predicting 10 million deaths by 2050 if current trends continue. He urged caution in antibiotic prescribing, stressing the importance of stewardship programs to mitigate risks associated with excessive antibiotic use.

Dr. Srinivas Samavedam, President-Elect of ISCCM, emphasized the role of multiple stakeholders in AMR control, advocating for judicious antibiotic use aligned with stewardship principles. He noted the need for patient education and compliance, stressing that antibiotics require time to be effective and cautioning against altering prescriptions without medical consultation.

Dr. Pradeep Rangappa, former Secretary of ISCCM, discussed India's high antibiotic consumption rate and the government's national action plan to regulate it. He highlighted the importance of surveillance and resistance pattern monitoring to inform effective antimicrobial strategies.

Dr. Rajesh Pande, principal director at BLK MAX Super Specialty Hospital, emphasized the dwindling pipeline of new antibiotics amidst rising AMR prevalence. He urged pharmaceutical companies to innovate and develop novel anti-infectives to combat drug-resistant bacteria effectively.

The experts agreed on the critical need for a multifaceted approach to address AMR, including surveillance systems, antibiotic stewardship programs, and stringent infection control measures. They stressed the importance of public awareness, responsible antibiotic use, and collaborative efforts across sectors to mitigate the growing threat of AMR and secure future healthcare sustainability.